To resume
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continued to mutate and spread in 2022 despite the introduction of safe and effective vaccines and drugs. The vaccine hesitancy it remains substantial, fueled in part by disinformation. Our third study on coronavirus disease 2019 (COVID-19) vaccine reluctance among 23,000 respondents in 23 countries (Brazil, Canada, China, Ecuador, France, Germany, Ghana, India, Italy, Kenya, Mexico, Nigeria, Peru, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Turkey, United Kingdom and United States ), interviewed from 29 June to 10 July 2022, found a willingness to accept vaccination of 79.1%, 5.2% more than in June 2021. Hesitation, however, raised in eight countries, from 1.0% (UK) to 21.1% (South Africa). Almost one in eight vaccinated respondents (12.1%) doubts booster doses. Overall support for vaccinating children under 18 rose slightly, but declined among personally hesitant parents. Nearly two in five (38.6%) of respondents reported paying less attention than before to new information about COVID-19, and support for vaccination mandates has declined. Nearly a quarter (24%) of those who fell ill reported taking medications to combat symptoms of COVID-19. Vaccination remains a cornerstone of the response to the COVID-19 pandemic, but broad public support remains elusive. This data can be used by healthcare system decision makers, professionals, advocates and researchers to more effectively address COVID-19 vaccine hesitancy.
